Table 1.
Baseline characteristics overall and by treatment group, Mean (SD) or N (%)
| Overall, N = 4,268 | Standard BP Goal, N = 2,151 | Intensive BP Goal, N = 2,117 | |
|---|---|---|---|
| Age, yr | 62.6 (6.6) | 62.6 (6.7) | 62.6 (6.5) |
| Female, N (%) | 1,987 (46.6) | 999 (46.4) | 988 (46.7) |
| Race, N (%) | |||
| White | 2,577 (60.4) | 1,273 (59.2) | 1,304 (61.6) |
| Black | 953 (22.3) | 495 (23.0) | 458 (21.6) |
| Hispanic | 279 (6.5) | 147 (6.8) | 132 (6.2) |
| Other | 459 (10.8) | 236 (11.0) | 223 (10.5) |
| Mean SBP, mm Hg | 139.0 (15.7) | 139.2 (15.4) | 138.9 (16.0) |
| Mean DBP, mm Hg | 75.9 (10.3) | 75.9 (10.2) | 75.9 (10.5) |
| Mean heart rate, mm Hg | 72.9 (11.6) | 72.8 (11.4) | 73.0 (11.8) |
| Body mass index, kg/m2 | 32.1 (5.5) | 32.1 (5.4) | 32.2 (5.6) |
| Fasting plasma glucose, mg/dl | 174.7 (57.5) | 173.5 (57.7) | 176.0 (57.3) |
| History of cardiovascular disease, N (%) | 1,409 (33.0) | 715 (33.2) | 694 (32.8) |
| History of myocardial infarction, N (%) | 581 (13.6) | 309 (14.4) | 272 (12.8) |
| History of stroke, N (%) | 255 (6.0) | 121 (5.6) | 134 (6.3) |
| History of heart failure, N (%) | 168 (3.9) | 78 (3.6) | 90 (4.3) |
| Smoking status, N (%) | |||
| Never | 1,901 (44.5) | 965 (44.9) | 936 (44.2) |
| Former | 1,821 (42.7) | 909 (42.3) | 912 (43.1) |
| Current | 546 (12.8) | 277 (12.9) | 269 (12.7) |
| Diuretic use, N (%) | 1,564 (36.6) | 790 (36.7) | 774 (36.6) |
| Central alpha antagonist, N (%) | 69 (1.6) | 25 (1.2) | 44 (2.1) |
| Beta blocker, N (%) | 1,170 (27.4) | 578 (26.9) | 592 (28.0) |
Abbreviations: BP, blood pressure; DBP, diastolic blood pressure; SBP, systolic blood pressure.